Women's Health Initiative - BioInnovation Institute

Women’s Health Initiative

Our focus areas

BII aims to support women’s health across a broad range of indication areas. We are especially interested in new non-hormonal therapeutics solutions, and evidence-based health tech approaches. For specifics, please click on the images below.

Funding Opportunities

BII offers several ways to apply for funding for your women’s health start-up or project. Currently, we have a special funding opportunity with Ferring Pharmaceuticals A/S through a Reproductive Medicine and Maternal Health track. Learn more by clicking the boxes below.


Women's Health Innovation Panel

Below you can read all the news related to BII’s Women’s Health Initiative.

About the initiative

BII’s Women’s Health Initiative aims to strengthen the European ecosystem for innovative translational research and start-ups that address the high medical unmet needs within women’s health.

Parts of the Women’s Health Initiative activities are supported by a grant from Bill & Melinda Gates Foundation.

As part of this joint initiative, BII will conduct a thorough landscape analysis and identify leading research and start-up opportunities for women’s health, with the potential for future funding from BII and partners.

BII will also undertake community-building and awareness-creating activities with selected key partners within the ecosystem.

You can get more information here

Supported start-up companies and projects

Meet our Women’s Health Team
About BII

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation to benefit people and society. As a non-profit institute, BII operates the company creation and acceleration programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per project and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation

Since the inauguration of BII in November 2018, BII has awarded 83 million euros to 88 high-growth start-up companies and translational projects.